Prescribers should monitor the FDAs bulk drug substances list for the formal update before ordering
When they are not working correctly, proteins can leak into the urine, causing the foamy appearance
Commercial Development: In August 2025, Jocasta Neuroscience raised $35 million in Series A funding to advance JN-0413, a proprietary -klotho formulation, through Phase 1 trials with IND submission planned for Q4 2026
Effects of cordycepin on the microglia-overactivation-induced impairments of growth and development of hippocampal cultured neurons
As opposed to cyanocobalamin, it is ready to be used by the body and is usually the most ideal and effective method for vitamin B12 injections
Neither is FDA approved for weight loss, and neither is backed by strong clinical evidence